Comparison of particle size distributions and volatile organic compounds exhaled by e-cigarette and cigarette users
Abstract
Abstract Vaping is promoted as a healthier alternative to smoking over the recent years, and e-cigarette (EC) users are considered to affect air quality (and thus contribute to passive smoking) much less than tobacco cigarette (TC) smokers. Here we test this hypothesis, by comparing measurements of the size distributions of particles and the levels of Volatile Organic Compounds (VOCs) exhaled by both EC and TC users. A total of 26 individuals (16 EC users and 10 TC users) provided exhaled air samples that were analyzed using the same protocol. Our measurements show that the particle number concentration emitted by both EC and TC users are comparable, but the size distributions of the particles emitted by the former exhibit significantly higher variability compared to those from the latter. The burden of the VOCs was much higher in the exhaled air of TC smokers compared to that of EC users. Although some of the VOCs measured in the exhaled air of EC users were expected, as they are used directly in the e-liquids, the collected mixtures were highly variable (i.e., varying significantly from case to case) with only 8 compounds being common among all individuals participating in the study. In contrast, we identified 65 compounds among the TC smokers that were common among the participants. Toxic compounds (e.g., benzene, acetaldehyde, toluene, xylenes, styrene, phenol, naphthalene, etc.) were also present in the exhaled air of EC users. The high variabilities observed in the…
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.